Navigation Links
Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
Date:9/8/2008

BANGKOK, Thailand, Sept. 8 /PRNewswire/ -- Don Margolis, Chairman of The Repair Stem Cell Institute LLC (RSCI; http://www.RepairStemCells.org) based in Bangkok, Thailand told The Wall Street Transcript (TWST) in an exclusive news interview published today that future profits inside the stem cell research sector will be hard to come by over the next five years, even for companies specializing in Repair Stem Cells (often called "adult stem cells"), where new life science discoveries are coming faster than anybody can keep up with. TWST is an international financial news weekly published in New York City (http://www.twst.com). Highlights from the TWST news interview can be read by visiting the RSCI web site.

According to Mr. Margolis, stem cell research companies that store umbilical cord blood cells for future use will have "the best shot at making the first profits once the public becomes aware how well these stem cells work." The RSCI Chairman is the founder of TheraVitae, the first stem cell company in the world to successfully treat dying heart patients with Repair Stem Cells.

Among the other predictions Mr. Margolis made in this TWST financial news interview were the following:

-- Wall Street has been discounting Embryonic Stem Cell (ESC) company stocks from 2004 through this summer when these stocks hit new lows;

-- There are 2100 Adult Stem Cell clinical trials listed at http://www.clinicaltrials.gov right now "for more diseases than I can count" said Margolis, "and these clinical trials means two things: First, thousands and thousands of human beings either have been treated, will be treated, or are being treated in these clinical trials by the only stem cells with a chance to improve their lives. Second, many powerful financial and investment leaders are spending hundreds of millions of dollars to fund these trials. They know that Repair Stem Cells are the future of medicine."

-- Margolis stated that "Embryonic Stem Cell (ESC) clinical trials are somewhere in the distant future, waiting for someone to discover an ESC which can be safely implanted into a human being." Six such attempts can be found at http://www.clinicaltrials.gov, but no treatments are even being considered.

Visit http://www.RepairStemCells.org/StemCellTreatmentCenters.php for RSCI's global listing of stem cell treatment centers and the doctors/researchers meeting the Institute's Standards of Excellence and are treating 100+ medical conditions.

About RSCI

The Repair Stem Cell Institute LLC (RSCI) is a global public service company dedicated to educating and informing the public about Repair Stem Cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with an administrative office in Dallas and its communications, government and political affairs office in Washington, D.C.


'/>"/>
SOURCE Repair Stem Cell Institute LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Excipients Help Pharma Extend Product Life, Profits
3. Early-Bird Registration Ends this Week for 10th Annual Quality Excellence Conference: How Process Improvement Leaders Produce Profits in Recessions
4. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
5. Social Network for Scientists Marks Ten Years Online
6. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
7. Dark energy -- 10 years on
8. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
9. Biotech Crops Experience Remarkable Dozen Years of Double-Digit Growth
10. Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years
11. Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
(Date:5/23/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.24 per share will ... of record as of the close of business on June ... of the Board of Directors and may be adjusted as ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... focused on molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman ... Feynman, are given in two categories, one for experiment and the other for ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers ... a new way to treat the disease. Surviving Mesothelioma has just posted an article ... from several Korean institutions based their mesothelioma study on the fact the Manumycin A, ...
Breaking Biology Technology:
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
Breaking Biology News(10 mins):